Trexquant Investment LP Uro Gen Pharma Ltd. Transaction History
Trexquant Investment LP
- $8.06 Billion
- Q4 2024
A detailed history of Trexquant Investment LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Trexquant Investment LP holds 172,551 shares of URGN stock, worth $1.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
172,551
Previous 271,670
36.49%
Holding current value
$1.6 Million
Previous $3.45 Million
46.75%
% of portfolio
0.02%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding URGN
# of Institutions
137Shares Held
36.2MCall Options Held
57.7KPut Options Held
9.8K-
Rtw Investments, LP New York, NY3.83MShares$35.6 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$27.2 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$21.4 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$20.4 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$16.2 Million0.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $211M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...